Publisher's Synopsis
Examines the environment for and obstacles to the development of anti-addiction medications, specifically those for treating opiate and cocaine addictions. This work proposes incentives for the pharmaceutical industry that would help overcome those obstacles and accelerate the development of anti-addiction medications.